Anti-HIV Med
Description
Anti-HIV Med is a simple tool for practising physicians, health care professionals, or anyone interested in HIV treatment. Basic information about each registered antiretroviral compound for treating HIV infection in Hong Kong can be accessed through its slide-out menu or search function.
Anti-HIV Med is developed by the HIV Research Team at Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong as an independent tool. This is also currently accessible as a supplement appended to HIV Manual 3rd Edition.
Hide
Show More...
Anti-HIV Med is developed by the HIV Research Team at Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong as an independent tool. This is also currently accessible as a supplement appended to HIV Manual 3rd Edition.
Screenshots
Anti FAQ
-
Is Anti free?
Yes, Anti is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Anti legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Anti cost?
Anti is free.
-
What is Anti revenue?
To get estimated revenue of Anti app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Chile yet.
Ratings History
Anti Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Anti Competitors
Anti Installs
Last 30 days
Anti Revenue
Last 30 daysAnti Revenue and Downloads
Gain valuable insights into Anti performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 1.4.2 (4 years ago )
- Released on
- Sep 19, 2013 (11 years ago )
- Also available in
- Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, South Africa, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Dominican Republic, Algeria, France, United Kingdom, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, India, Italy, Poland, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Greece, Brazil, Türkiye, Taiwan, Ukraine, United States, Vietnam, Egypt, Spain, Finland, United Arab Emirates, Argentina, Austria, Australia, Azerbaijan, Belgium, Belarus, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Ecuador
- Last Updated
- 2 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.